Andrew Witty was interviewed on CNBC-TV's "Power Lunch" programme on Tuesday 22 June.
Andrew Witty, GlaxoSmithKline's CEO, has taken questions from listeners to the BBC's World Have Your Say programme.
Nelson from Nigeria started the questioning, which covered the quality of products in Africa, transparency, the patent pool for sharing knowledge of diseases and the stockpiles of flu medicines.
World Malaria Day was established in March 2007. Its aim is to provide education and understanding of malaria as a global scourge that is preventable and a disease that is curable.
Our efforts against malaria are a key part of our commitment to finding new ways to treat the World Health Organization's three priority diseases of HIV/AIDS, tuberculosis and malaria.
20 January 2010: Andrew Witty, during a speech at the Council on Foreign Relations, announced an ‘open innovation’ strategy to help deliver new and better medicines for people living in the world’s poorest countries.
For more information, please read the press release, available in six languages:
Referring to his speech given at the Council on Foreign Relations in New York on 20 January 2010, Mr Witty said,“We want to be a company that is truly a partner in addressing the healthcare challenges in the world's poorest countries, no matter how difficult they are. A restless company, never satisfied with what it has achieved, but always looking for ways of doing more."
Policy on pricing for Least Developed Countries
On 13 February 2009, Andrew Witty announced that GSK would reduce its prices for patented medicines in Least Developed Countries (LDCs) so they are no higher than 25% of the price in the developed world providing this covers the cost of goods.